Trademarkia Logo

Canada

C$
RIBOTECT
REGISTERED

on 2 Mar 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

BIONTECH SE

An der Goldgrube 1255131 Mainz

DE

Serial Number

1987012 filed on 6th Aug 2019

Registration Number

TMA1121578 registered on 2th Mar 2022

Registration expiry Date

6th Aug 2029

Correspondent Address

NELLIGAN O'BRIEN PAYNE LLP

300-50 O'CONNOR STREETOTTAWA

ONTARIO

CA

K1P6L2

RIBOTECT

Trademark usage description

chemical products for medical and veterinary use for the diagnosis of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects a Read More

Classification Information


Class [005]
Chemical products for medical and veterinary use for the diagnosis of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects and metabolic disorders; medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles or lipid-based emulsions for the treatment of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects and metabolic disorders; medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleic acids for the treatment of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders.


Classification kind code

11

Class [042]
Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions.


Classification kind code

11

Class [044]
Medical services and veterinary services for the treatment of cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders.


Classification kind code

11

Mark Details


Serial Number

1987012

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 5th Jan 2021
Search Recorded
Submitted for opposition 20
on 5th Jan 2021
Examiner's First Report
Submitted for opposition 223
on 5th Jan 2021
Total Provisional Refusal
Submitted for opposition 256
on 27th Jul 2020
Notification of Possible Opposition Sent
Submitted for opposition 48
on 11th Mar 2020
Agent Changed
Submitted for opposition 257
on 26th Sept 2019
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 26th Sept 2019
Created
Submitted for opposition 31
on 26th Sept 2019
Formalized
Submitted for opposition 30
on 6th Aug 2019
Filed
Submitted for opposition 228
on 6th Aug 2019
International Registration